Tokyo Tape
Sign in
← Nissan Chemical Corporatiom

Quarterly report · Q2

4021.TEDINET S100PLK3
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed

Amended by S100QA13 (2023-02-21).

Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥109.5bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥208.0bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥91.8bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥28.2bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥21.3bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥32.0bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥53.7bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥22.3bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥32.0bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥22.3bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥23.7bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥38.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥16.3bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income¥24.1bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥16.4bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥280.2bnat 2022-09-30Cons.Assets
Total assets¥279.7bnat 2022-03-31Cons.Assets
Total assets¥247.4bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥60.8bnat 2022-09-30Cons.Liabilities
Total liabilities¥71.7bnat 2022-03-31Cons.Liabilities
Net assets / equity¥219.4bnat 2022-09-30Cons.Net assets
Net assets / equity¥208.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥197.4bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥43.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥34.7bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥43.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥34.7bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥28.4bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥32.4bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥43.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥41.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥33.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥9.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥12.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥6.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥29.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥27.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥31.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥167.742022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥69.582022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥271.882021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥113.942021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.182021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio77.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio73.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio79.1%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 63
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-09-30¥12.4bn
Otherother segmentsrevenue external2022-04-01 → 2022-09-30¥5.3bn
Otherother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥7.2bn
Otherother segmentssegment profit2022-04-01 → 2022-09-30¥100m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥51.3bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-09-30−¥14.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥36.9bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥2.3bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥35.7bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥31.2bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.5bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥12.1bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥19.8bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.7bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6.0bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue2022-04-01 → 2022-09-30¥42.0bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-09-30¥34.0bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥8.0bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-09-30¥13.9bn
jpcrp040300-q2r_E00759-000Medicinesreportable segmentrevenue2022-04-01 → 2022-09-30¥3.2bn
jpcrp040300-q2r_E00759-000Medicinesreportable segmentrevenue external2022-04-01 → 2022-09-30¥3.2bn
jpcrp040300-q2r_E00759-000Medicinesreportable segmentsegment profit2022-04-01 → 2022-09-30¥1.5bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue2022-04-01 → 2022-09-30¥47.6bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue external2022-04-01 → 2022-09-30¥36.5bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥11.1bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentsegment profit2022-04-01 → 2022-09-30¥2.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥160.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥123.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥36.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥30.5bn
Otherother segmentsrevenue2021-04-01 → 2021-09-30¥10.4bn
Otherother segmentsrevenue external2021-04-01 → 2021-09-30¥4.4bn
Otherother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥6.0bn
Otherother segmentssegment profit2021-04-01 → 2021-09-30−¥3m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥39.9bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2021-09-30−¥10.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥29.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥2.5bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥24.9bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥22.8bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥2.1bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥6.9bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥17.1bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥11.7bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5.4bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.2bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue2021-04-01 → 2021-09-30¥39.6bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue external2021-04-01 → 2021-09-30¥34.0bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5.6bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentsegment profit2021-04-01 → 2021-09-30¥13.1bn
jpcrp040300-q2r_E00759-000Medicinesreportable segmentrevenue2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E00759-000Medicinesreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E00759-000Medicinesreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥19m
jpcrp040300-q2r_E00759-000Medicinesreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.4bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue2021-04-01 → 2021-09-30¥36.4bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue external2021-04-01 → 2021-09-30¥25.7bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥10.8bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥131.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥101.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥29.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥23.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 576
ItemContextValueUnit
Long term loans receivableCurrentQuarterInstant0JPY
Deferred tax assetsPrior1YearInstant918000000JPY
Deferred tax assetsCurrentQuarterInstant467000000JPY
Net defined benefit assetPrior1YearInstant1844000000JPY
Net defined benefit assetCurrentQuarterInstant2497000000JPY
Other ioaPrior1YearInstant3256000000JPY
Other ioaCurrentQuarterInstant3110000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-110000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-110000000JPY
Investments and other assetsPrior1YearInstant39450000000JPY
Investments and other assetsCurrentQuarterInstant35859000000JPY
Noncurrent assetsPrior1YearInstant104408000000JPY
Noncurrent assetsCurrentQuarterInstant108416000000JPY
AssetsPrior1YearInstant279687000000JPY
AssetsCurrentQuarterInstant280233000000JPY
Notes and accounts payable tradePrior1YearInstant19043000000JPY
Notes and accounts payable tradeCurrentQuarterInstant19019000000JPY
Short term loans payablePrior1YearInstant20981000000JPY
Short term loans payableCurrentQuarterInstant8235000000JPY
Current portion of long term loans payablePrior1YearInstant552000000JPY
Current portion of long term loans payableCurrentQuarterInstant510000000JPY
Income taxes payablePrior1YearInstant8710000000JPY
Income taxes payableCurrentQuarterInstant7974000000JPY
Provision for bonusesPrior1YearInstant2285000000JPY
Provision for bonusesCurrentQuarterInstant2345000000JPY
Other clPrior1YearInstant14398000000JPY
Other clCurrentQuarterInstant17442000000JPY
Current liabilitiesPrior1YearInstant65971000000JPY
Current liabilitiesCurrentQuarterInstant55527000000JPY
Long term loans payablePrior1YearInstant1182000000JPY
Long term loans payableCurrentQuarterInstant948000000JPY
Deferred tax liabilitiesPrior1YearInstant69000000JPY
Deferred tax liabilitiesCurrentQuarterInstant104000000JPY
Provision for business structure improvement nclPrior1YearInstant698000000JPY
Provision for business structure improvement nclCurrentQuarterInstant544000000JPY
Provision for loss on business of subsidiaries and affiliates nclPrior1YearInstant626000000JPY
Provision for loss on business of subsidiaries and affiliates nclCurrentQuarterInstant626000000JPY
Provision for share based remuneration for directors and other officers nclPrior1YearInstant200000000JPY
Provision for share based remuneration for directors and other officers nclCurrentQuarterInstant170000000JPY
Net defined benefit liabilityPrior1YearInstant290000000JPY
Net defined benefit liabilityCurrentQuarterInstant350000000JPY
Other nclPrior1YearInstant2638000000JPY
Other nclCurrentQuarterInstant2567000000JPY
Noncurrent liabilitiesPrior1YearInstant5706000000JPY
Noncurrent liabilitiesCurrentQuarterInstant5312000000JPY
LiabilitiesPrior1YearInstant71678000000JPY
LiabilitiesCurrentQuarterInstant60839000000JPY
Capital stockPrior1YearInstant18942000000JPY
Capital stockCurrentQuarterInstant18942000000JPY
Capital surplusPrior1YearInstant13613000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass